NCT03664453View on ClinicalTrials.gov

A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Healthy
Interventions
DRUG

omaveloxolone

Omaveloxolone 50 mg capsules

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY